Tan Y, Lv Z P, Bai X C, Liu X Y, Zhang X F
School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
J Ethnopharmacol. 2006 Apr 21;105(1-2):69-75. doi: 10.1016/j.jep.2005.09.040. Epub 2005 Nov 15.
Previous studies have demonstrated that traditional Chinese medicine Bao Gan Ning, which contains six different drugs: Trionyx sinensis Wiegmann shell, Prunus persica (L.) Batsch seed, Salvia miltiorrhiza Bge. root, Mallotus opelta (Lour.) Muell-Arg root, Astragalus membranaceus (Fisch.) Bge. var. mongho-licus (Bge.) Hsiao root and Scutellaria baicalensis Georgi root, was able to protect liver against fibrosis in CCL4 models. In an effort to elucidate molecular mechanisms by which Bao Gan Ning exerts its anti-fibrosis activity, effects of Bao Gan Ning on liver fibrosis and cAMP response element binding protein (CREB), an important transcription factor involved in liver fibrosis, were evaluated in animal and cell models in this work. Results showed that Bao Gan Ning (2.16 or 4.32 g/kg/day) significantly decreased alanine aminotransferase (ALT) and hyaluronidase levels and reversed liver fibrosis in rat liver fibrosis models. The proliferation of HSC-T6, a hepatic stellate cell line, was also significantly inhibited by incubation with serums that were prepared from rats fed with Bao Gan Ning. Most interestingly, results from Western blot, immunohistochemistry and electrophoretic mobility shift assay (EMSA) showed that Bao Gan Ning up-regulated CREB phosphorylation both in rat liver fibrosis models and in HSC-T6 cells, but did not affect protein level of CREB and the DNA binding activity of CREB. These results suggested that up-regulation of CREB phosphorylation may be involved in anti-fibrosis activity of Chinese medicine Bao Gan Ning.
以往研究表明,中药保肝宁(由六种不同药物组成:中华鳖甲、桃仁、丹参、山漆茎、蒙古黄芪根和黄芩根)能够在四氯化碳模型中保护肝脏免受纤维化影响。为阐明保肝宁发挥抗纤维化活性的分子机制,本研究在动物和细胞模型中评估了保肝宁对肝纤维化以及环磷酸腺苷反应元件结合蛋白(CREB,一种参与肝纤维化的重要转录因子)的影响。结果显示,在大鼠肝纤维化模型中,保肝宁(2.16或4.32克/千克/天)显著降低了丙氨酸转氨酶(ALT)和透明质酸酶水平,并逆转了肝纤维化。用保肝宁喂养的大鼠血清孵育肝星状细胞系HSC-T6,其增殖也受到显著抑制。最有趣的是,蛋白质印迹、免疫组织化学和电泳迁移率变动分析(EMSA)结果表明,保肝宁在大鼠肝纤维化模型和HSC-T6细胞中均上调了CREB磷酸化水平,但不影响CREB的蛋白水平及其DNA结合活性。这些结果提示,CREB磷酸化上调可能参与了中药保肝宁的抗纤维化活性。